Insulin tregopil (Biocon)

N/A

Report date: 2024/02/21 14:41:22

Base Information

Drug NameInsulin tregopil (Biocon)
Drug Alias NameOral prandial insulinHexyl insulin monoconjugate 2Hexyl Insulin M2GW-843362NIN-058 +[7] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionInsulin receptor agonists
TargetsInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermanyIndia
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBiocon Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiocon Ltd
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1

Other Information

ATC CodeN/A
Related LinksDrugBank